Cancer Therapeutics

Cancer & Therapeutics

Award: MSc / PG Diploma

Modes of Study: Full Time / Part Time / Full Time - Distance Learning / Part Time - Distance Learning

Course Director: Dr Richard Grose

Start Date: September

[accordion]

Overview

This programme is designed to provide students with a clear understanding of the scientific principles underlying the field of cancer therapeutics and the development, evaluation and implementation of new treatments. By the end of the course, in addition to expertise covering the full arsenal of cancer therapeutics, you will be equipped with a thorough knowledge of cancer biology and pathology, research methodologies, drug development, and regulatory issues.

Students will be provided with a firm grounding in the use and evaluation of cancer therapies, which will enhance your career prospects in many areas of cancer research, early phase clinical trials, Allied Health Professions and the pharmaceutical industry.

Structure

Full Time

Semester 1: September - December (45 or 52.5 credits taught modules)
Semester 2: January - March (75 or 67.5 credits taught modules)
Semester 3: May - August (60 credit Dissertation, MSc only)

Part Time

Year 1

Semester 1: September - December (30 or 37.5 credits taught modules)
Semester 2: January - March (30 or 22.5 credits taught modules)

Year 2

Semester 1: September - December (15 or 22.5 credits taught modules)
Semester 2: January - March (45 or 37.5 credits taught modules)
Semester 3: May - August (60 credit Dissertation, MSc only)

Exams

Semester 1: January      Semester 2: March/April       Semester 3: August resits


Each 15 credit module involves approximately 30 hours contact time and 120 hours of self-study.

Each 7.5 credit module involves approximately 15 hours contact time and 60 hours of self-study.

The Dissertation is carried out full time over 12 weeks with regular supervision from one of the Institute’s research centres. There may be some flexibility to arrange part time dissertations for part time students who are unable to commit to completing this full time. These are arranged on a case by case basis in consultation with the Programme Director.

Modes of Study

Award and structure

MSc: 120 taught credits + 60 credit Dissertation
PG Diploma: 120 taught credits

A variety of study options are available, these include Full Time (1 year) and Part Time (2 years), on-site or by Distance Learning.

Distance Learning

Distance learning is delivered via the University’s online learning platform - QMplus. Onsite lectures are recorded and made available to Distance Learning students, together with copies of the slides and other supporting teaching materials.
Dissertations will be supervised by a Barts Cancer Institute researcher and supervision meetings will be conducted by telephone or by Skype.

Assessment

Posters and oral presentations will be delivered via Skype.
Examinations can be at Queen Mary University of London or at an approved local venue (usually a British Council or a local Academic Institution).

Content

Compulsory modules

Research Methods
Cancer Biology
Cancer Pharmacology
Molecular Diagnostics & Therapeutics
Molecular Targeted Therapies and Immunotherapy for Blood Cancers
Site Specific Tumour Treatment
Ablative Therapy
Drug Development
Cancer Prevention & Screening
Dissertation (MSc only)

Optional modules (select 2)

Pathology of Cancer
Genomic Approaches to Cancer
Paediatric & Adolescent Oncology

For more detailed module information click here

Entry Requirements and How to Apply

Academic Entry Requirements

A medical degree or a Bachelor’s degree in a relevant subject from a recognised institution with 2:1 or better or an appropriate professional qualification. Applicants with a 2:2 and strong supporting evidence will also be considered.

For international equivalencies please see the QMUL International Office.

English Language Requirements

Applicants for whom English is not a first language will also require a minimum IELTS score of 7 (with 5.5 in each component) or equivalent, unless their undergraduate degree was studied in, and awarded by, an English speaking country. For more information on acceptable English language qualifications please click here.

How to apply

All applications must be completed online.

As part of your application you will be required to provide the following documents:

  • Personal Statement
  • CV
  • 2 references (at least one of these must be an academic reference)
  • Copies of degree transcripts
  • English language results and certificate (if applicable)

Fees and Funding

MSc

£8,650 (Home/EU students)
£20,600 (Overseas students)

PG Diploma

£5,850 (Home/EU students)
£13,750 (Overseas students)

2017-2018 Tuition fees


Funding and scholarships

Numerous funding options are available to Postgraduate students. For more information click here.

Deposit

Due to receiving large volumes of successful applications, it is our department policy to request a deposit of £2000 from overseas students and £1000 from home/EU students in order to secure your place on the course. This will be payable on acceptance of an offer.

Career Prospects

Career pathways include:

  • Clinical rials
  • Allied Health Professions
  • Pharmaceutical Industry
  • Academia
  • Medicine

Each year we retain a proportion of our graduates within the Institute as PhD students, research assistants or clinical trials co-ordinators.

[/accordion]

If you cannot find the information you are looking for, please browse our FAQs or email bci-cancercourses@qmul.ac.uk.

Contact Details & Location

  • bci-cancercourses@qmul.ac.uk
  • +44(0) 20 7882 2081
    +44(0) 20 7882 3847
  • Barts Cancer Institute
    Teaching Centre,
    Joseph Rotblat Building,
    Charterhouse Square,
    London EC1M 6BQ
This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.